- Telehealth Visits
- Insurance plan information
- Provider Type: Physician
Vadim S. Koshkin, MD
Medical Oncology (Genitourinary Cancer)- Telehealth Visits
- Insurance plan information
- Provider Type: Physician
Vadim S. Koshkin, MD
Medical Oncology (Genitourinary Cancer)On this page
About me
Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are.
In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors.
After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network.
A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time.
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, Cleveland Clinic-GME
Residency
- Internal Medicine, University of Michigan Hospitals GME
Internship
- Internal Medicine, University of Michigan Hospitals GME
Degree
- MD, University of Chicago Pritzker School of Medicine
Academic title
- Clinical Professor
My expertise
Locations
My research
Clinical trials
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Opens in a new window
Recruiting
The proportion of participants with confirmed complete response (CR) or partial response (PR) according to RECIST v1.1Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate CancerOpens in a new window
Recruiting
If two or more patients in a cohort experience a dose-limiting toxicity (DLT), then the maximum tolerated dose (MTD)has been exceeded. The previous dose level...A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerOpens in a new window
Recruiting
Complete response will be determined by bladder biopsy and urinary cytology for malignancy for subjects with a CIS component at 6 months CT/MRI urography will...Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder CancerOpens in a new window
Recruiting
The RP2D is the last dose cohort at which no more than one instance of a dose limiting toxicity (DLT) is observed among 6 participants treated. If the maximum...
Publications
Showing 1-6 of 30 reviews
- August 20, 20265 out of 5 Stars
Dr Koshkin and his team is very good doctor, he listened to our concerns very will and answer our questions and concerns and provide a very thorough explanation. He is very knowledgeable and shows how patient centered he is. I would highly recommend him, the fact that he is willing to answer any questions that we have even on the email tells me that he is not just a doctor who is doing his job, but a professional specialist who care about the patient.
- July 9, 20265 out of 5 Stars
Dr. Koshkin is a very engaged provider and provides excellent care.
- June 25, 20265 out of 5 Stars
Dr. Koshkin is very thorough and listened well to any of my concerns.
- May 29, 20265 out of 5 Stars
I may be biased in my answers as I believe my care provider saved my life.
- May 19, 20265 out of 5 Stars
Considerate informative and helpful
- March 17, 20265 out of 5 Stars
Of all of my Care Providers, this is my best one.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.